GASTROPARESIS TREATMENT MARKET ANALYSIS

Global gastroparesis treatment market growth can be hampered due to high cost associated with treatment procedures. Gastroparesis often requires costly surgeries or other interventional procedures to manage symptoms. Surgical procedures like pyloroplasty and gastrojejunostomy aim to improve gastric emptying but are expensive. Even minor procedures and implanted drug delivery devices are expensive. The development and adoption of new treatment options is also slowed by the heavy investment required in research and clinical trials. Increasing healthcare costs have further exacerbated the issue and put gastroparesis treatment out of reach for patients from lower socioeconomic backgrounds. Addressing the expense of gastroparesis management remains a major obstacle to improving care and quality of life for affected individuals around the world.

Market Opportunity: Developing regions with large patient pool

Developing regions of the world present a major opportunity for gastroparesis treatment market growth due to their huge populations and increasing disease burden. Countries in Asia Pacific, Latin America, Middle East and Africa are witnessing rising incidence of gastroparesis, owing to growing obese and diabetic populations. At the same time, there is abundant room for penetration of new treatment products in these underserved markets where awareness and access to care is currently low. International players can gain a significant customer base by catering to the needs of developing healthcare systems and collaborating with local pharma companies. Low manufacturing costs allow firms to offer products at affordable price points tailored for price-sensitive markets. This helps address a large unmet medical need while also expanding revenues.